Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Clinical trial NCT02019576 · COMPLETED

Trial details

NCT number: NCT02019576
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Metastatic Renal Cell Carcinoma

Start date: 2014-05-01
Primary completion: 2021-02-16
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.